SCHEMBL17202852

SCHEMBL17202852

Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO[C@H](O)CP(=O)(O)O)[C@H](O)[C@H]1O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RY1 P47900 5/20 0.72
▸ P2RY2 P41231 3/20 0.72
▸ SRC P12931 2/20 0.72
▸ SMN1; SMN2 Q16637 2/20 0.72
▸ TRPM2 O94759 2/20 0.72
▸ TAS1R3 Q7RTX0 2/20 0.72
▸ TAS1R1 Q7RTX1 2/20 0.72
▸ DNPH1 O43598 1/20 0.72
▸ PRKAB2 O43741 1/20 0.72
▸ LDHA P00338 1/20 0.72
▸ ADRB2 P07550 1/20 0.72
▸ FBP1 P09467 1/20 0.72
▸ ADORA1 P30542 1/20 0.72
▸ PRKAG1 P54619 1/20 0.72
▸ PRKAA2 P54646 1/20 0.72
▸ PDE4D Q08499 1/20 0.72
▸ KCNH2 Q12809 1/20 0.72
▸ PRKAA1 Q13131 1/20 0.72
▸ PDE3A Q14432 1/20 0.72
▸ P2RY11 Q96G91 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17202732 1.00 P2RY1 (0.72) P2RY1P2RY2SRCSMN1; SMN2TRPM2
SCHEMBL21947634 0.88 P2RY1 (0.74) P2RY1P2RY2SRCSMN1; SMN2TRPM2
SCHEMBL17206372 0.88 P2RY1 (0.74) P2RY1P2RY2SRCSMN1; SMN2TRPM2
SCHEMBL17202728 0.88 P2RY1 (0.74) P2RY1P2RY2SRCSMN1; SMN2TRPM2
SCHEMBL17202843 0.88 P2RY1 (0.74) P2RY1P2RY2SRCSMN1; SMN2TRPM2
SCHEMBL17213455 0.87 NT5E (0.77) P2RY1P2RY2SRCSMN1; SMN2TRPM2
SCHEMBL23915700 0.84 RNASEL (0.82) P2RY1P2RY2SRCSMN1; SMN2TRPM2
SCHEMBL13996419 0.84 P2RY1 (0.85) P2RY1P2RY2SRCSMN1; SMN2TRPM2
SCHEMBL30395044 0.84 RNASEL (0.82) P2RY1P2RY2SRCSMN1; SMN2TRPM2
SCHEMBL21839669 0.84 RNASEL (0.82) P2RY1P2RY2SRCSMN1; SMN2TRPM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3134411-A1 PURINE DERIVATIVES AS CD73 INHIBITORS FOR THE TREATMENT OF CANCER Vitae Pharmaceuticals, Inc. (US) 2017-03-01 — — EP claimed
WO-2015164573-A1 PURINE DERIVATIVES AS CD73 INHIBITORS FOR THE TREATMENT OF CANCER VITAE PHARMACEUTICALS, INC. (US) 2015-10-29 — — WO claimed
EP-3134411-A1 PURINE DERIVATIVES AS CD73 INHIBITORS FOR THE TREATMENT OF CANCER Vitae Pharmaceuticals, Inc. (US) 2017-03-01 — — EP disclosed
WO-2015164573-A1 PURINE DERIVATIVES AS CD73 INHIBITORS FOR THE TREATMENT OF CANCER VITAE PHARMACEUTICALS, INC. (US) 2015-10-29 — — WO disclosed
Send feedback